Click here to read the full article

If this link is broken, please Click here to let the webmaster know.

ALERT is not responsible for the content of this site.

When you are ready to retun to ALERT hit your browser's back button.

Background: Most end-of-life decision-making studies have, until now, involved either the general population or newborn infants.

Objective: To assess the frequency of end-of-life decision spreceding child death and the characteristics of the decision-making process in the Netherlands.

Methods: Two studies were performed. The first was a death certificate study in which all 129 physicians reporting the death of a child aged between 1 and 17 years in the period August to December 2001 received a written questionnaire; the second was an interview study in which face-to-face interviews were held with 63 physicians working in pediatric hospital departments.

Results: Some 36% of all deaths of children between the ages of 1 and 17 years during the relevant period were preceded by an end-of-life decision: 12% by a decision to refrain from potentially life-prolonging treatment; 21% by the alleviation of pain or symptoms with a possible life-shortening effect; and 2.7% by the use of drugs with the explicit intention of hastening death. The latter decision was made at the child’s request in 0.7% and at the request of the family in 2% of cases. The interview study examined 76 cases of end-of-life decision making. End-of-life decisions were discussed with all 9 competent and 3 partly competent children, with the parents in all cases, with other physicians in 75 cases, and with nurses in 66 cases.

Conclusions: While not inconsiderable, the percentageof end-of-life decisions was lower for children than for adults and newborn infants. Most children are not considered to be able to participate in the decision-making process. Decisions are generally discussed with parents and other caregivers and, if possible, with the child.

Arch Pediatr Adolesc Med. 2005;159:802-809